66 results on '"Schueler, S"'
Search Results
2. HVAD Decommission in a Failing Mustard: Making Virtue out of Necessity
3. A Review of Ventricular Assist Device Patients’ Compliance in INR Reporting Using a New App-Based Programme Compared with Telephone Surveillance
4. An Analysis of Implant Approach and Impact on Early Outcomes in Real-World Use of the HeartWare™ HVAD™ System
5. Markers of Right Ventricle Dysfunction Predict Exercise Capacity on Left Ventricular Assist Device (LVAD) Patients
6. Left Ventricular Assist Device Decommissioning, the Journey so Far - Single Centre Experience
7. The BEAT Device for Intrathoracic, Extracardiac Biventricular Mechanical Circulatory Support for Advanced Heart Failure
8. Ventricular Assist Devices in Adults with Failing Systemic Right Ventricle: The Importance of Concomitant Tricuspid Valve Replacement
9. Outcomes Following Elective Temporary RVAD Support in Patients Who are Undergoing LVAD Implantation: A Bridge Too Far?
10. A Simplified Temporary Right Ventricular Assist Device (RVAD) during LVAD Implantation - Low Risk, Easy to Do and Ideal for Patient Rehabilitation
11. Elevation of Right-Sided Pressures and Right Ventricular Echocardiographic Parameters: Predictors of Exercise Limitation in Patients with Implanted Continuous Flow Left Ventricular Assist Devices
12. Long-Term Outcomes of Heartware Left Ventricular Assist Device Decommissioning for Myocardial Recovery
13. Cost-Effectiveness of a Small Intrapericardial Centrifugal LVAD versus Medical Management in Destination Therapy Patients in the UK
14. A Review of Ventricular Assist Device Patients Compliance in INR Reporting Using a New App-Based Programme Compared with Telephone Surveillance
15. Ventricular Assist Device for Failing Systemic Right Ventricle in Biventricular Physiology: The Role of Concomitant Tricuspid Valve Replacement. Early Results
16. Tricuspid Regurgitation Predicts Late Onset Right Heart Failure after Left Ventricular Assist Device Implantation
17. A New Less Invasive Technique of RVAD Insertion - Time to Lower the Threshold around LVAD Insertion
18. Lack of Social Support is Not a Contraindication to VAD Therapy
19. MSSA Bacteraemia Can Be Eliminated in LVAD Patients
20. Level of Power Increase on Admission Determines Successful Treatment with Enhanced Anticoagulation with HeartWare Ventricular Assist Device Thrombosis
21. The Outcome of Cardiac Transplantation in Patients With Down Syndrome
22. Outcomes of Durable Mechanical Circulatory Support in Myocarditis: Analysis of the IMACS Registry
23. Infection Predisposes to Thrombosis During Long Term VAD Support
24. Patient Survival and Therapeutic Outcomes in the UK Bridge to Heart Transplant Ventricular Assist Device Population
25. The Introduction of a Super-Urgent Heart Allocation Scheme in the United Kingdom
26. LVADs as Bridge to Candidacy in the UK
27. High-Risk and Low-Risk Donor/Recipient Characteristics and 90-Day Transplant Outcomes in LVAD versus Standard Recipients
28. Heparin Induced Thrombocytopenia Type II in Mechanical Circulatory Support Recipients
29. The Epidemiology of Infection in MCS from the IMACS Database: January 2013 to December 2015
30. Epidemiology of Bloodstream Infections in MCSD Recipients in the IMACS Registry
31. Ventricular Arrhythmias in Long Term LVAD Patients - Life Threatening Situation or Nothing to Worry About?
32. Durable LeftVentricular Assist Device Therapy to Reduce Transpulmonary Gradient in Adult Congenital Heart Disease to Facilitate Heart Transplant
33. Savvy Liars? HEXACO personality predicts self-report deception ability
34. A Review of Warfarin Management in Patients Supported with a Heartware HVAD Using Home INR Testing
35. Agreeing to Disagree: A Comparison of Antiplatelet and Anticoagulant Management Strategies at US versus International HVAD Implanting Centers
36. Impact of Aortic Valve Closure on Adverse Events and Outcomes with the HeartWare HVAD
37. 500 Multiparametric magnetic resonance imaging and MRI/TRUS-fusion-biopsy for index tumor detection: Correlation with radical prostatectomy specimen
38. Long Term Measurements of Aortic Root and Left Ventricular Dimensions in Patients on HeartWare® Ventricular Assist Device - An Explanation for the Development of Aortic Incompetence in Chronic LVAD Support?
39. Long Term Support of Patients Receiving an LVAD for Advanced Heart Failure: A Subgroup Analysis of the Registry to Evaluate the HeartWare® Left Ventricular Assist System (The REVOLVE Registry)
40. Effective Transcutaneous Energy Transfer Allows for More Than 6 Hours of Freedom From External Gear - The Future Is Here
41. A New Outpatient Surveillance Program Improves Home Based Care in Long Term LVAD Recipients
42. Extended Bridge To Transplant: 4 Years Outcomes With 3rd Generation LVADs in an Era of Restricted Transplantation
43. Mechanical Circulatory Support for Failing Systemic Right Ventricle Using Left Ventricular Assist Device - An Option To Decide and Bridge?
44. Development of De-Novo Aortic Valve Incompetence in Patients With the Continuous Flow Heartware® Ventricular Assist Device
45. Long Term Analysis of RV Function in Patients After Continuous Flow Heartware® LVAD Implantation Without the Need for Peri-Operative Mechanical RV Support - Honeymoon Period or Sustainable Success?
46. Socio-Economic Classification Is a Predicator of Long Term Survival in Patients With Left Ventricualr Assist Device
47. A New Universal Wireless Transcutaneous Energy Transfer (TET) System for Implantable LVADs – Preliminary In Vitro and In Vivo Results
48. Improving Outcomes in Lung Transplantation for Cystic Fibrosis – A Unified Approach
49. Driveline Exit Site in Long Term LVAD’s – Patient Choice or Surgeon’s Decision
50. 777 Left Ventricular Assist Device Implantation Significantly Improves Everyday Physical Activity and Quality of Life in Patients with Chronic Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.